Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
4
Filing Date
2/16/2026
Updated
2/17/26, 5:26 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership